Clinical Trials Browser

OTHER × Penile Squamous Cell Carcinoma (PSCC) × enfortumab vedotin × Clear all

NCT07110038 2026-04-16

DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma

Phase 2 Recruiting

Penile Squamous Cell Carcinoma (PSCC)